Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 844

1.

Discovery of Heterotopic Bone-Inducing Activity in Hard Tissues and the TGF-β Superfamily.

Katagiri T, Tsukamoto S, Nakachi Y, Kuratani M.

Int J Mol Sci. 2018 Nov 13;19(11). pii: E3586. doi: 10.3390/ijms19113586. Review.

2.

Signal Intensity of the Cerebrospinal Fluid after Intravenous Administration of Gadolinium-based Contrast Agents: Strong Contrast Enhancement around the Vein of Labbe.

Ohashi T, Naganawa S, Ogawa E, Katagiri T, Kuno K.

Magn Reson Med Sci. 2018 Nov 9. doi: 10.2463/mrms.mp.2018-0043. [Epub ahead of print]

3.

A prospective study to examine the accuracies and efficacies of prediction systems for response to neoadjuvant chemotherapy for muscle invasive bladder cancer.

Kato Y, Zembutsu H, Takata R, Matsuura T, Kato R, Kanehira M, Iwasaki K, Yamada N, Katagiri T, Sugai T, Fujioka T, Nakamura Y, Obara W.

Oncol Lett. 2018 Nov;16(5):5775-5784. doi: 10.3892/ol.2018.9330. Epub 2018 Aug 20.

4.

Cladribine treatment for Erdheim-Chester disease involving the central nervous system and concomitant polycythemia vera: A case report.

Tamura S, Kawamoto K, Miyoshi H, Suzuki T, Katagiri T, Kasami T, Nemoto H, Miyakoshi S, Kobayashi H, Shibasaki Y, Masuko M, Takeuchi K, Ohshima K, Sone H, Takizawa J.

J Clin Exp Hematop. 2018 Dec 13;58(4):161-165. doi: 10.3960/jslrt.18015. Epub 2018 Oct 10.

5.

Germline pathogenic variants of 11 breast cancer genes in 7,051 Japanese patients and 11,241 controls.

Momozawa Y, Iwasaki Y, Parsons MT, Kamatani Y, Takahashi A, Tamura C, Katagiri T, Yoshida T, Nakamura S, Sugano K, Miki Y, Hirata M, Matsuda K, Spurdle AB, Kubo M.

Nat Commun. 2018 Oct 4;9(1):4083. doi: 10.1038/s41467-018-06581-8.

6.

Recent Topics in Fibrodysplasia Ossificans Progressiva.

Katagiri T, Tsukamoto S, Nakachi Y, Kuratani M.

Endocrinol Metab (Seoul). 2018 Sep;33(3):331-338. doi: 10.3803/EnM.2018.33.3.331. Review.

7.

Discovery of DS42450411 as a potent orally active hepcidin production inhibitor: Design and optimization of novel 4-aminopyrimidine derivatives.

Fukuda T, Ishiyama T, Katagiri T, Ueda K, Muramatsu S, Hashimoto M, Aki A, Baba D, Watanabe K, Tanaka N.

Bioorg Med Chem Lett. 2018 Nov 1;28(20):3333-3337. doi: 10.1016/j.bmcl.2018.09.010. Epub 2018 Sep 8.

PMID:
30217414
8.

Critical Role of Estrogen Receptor Alpha O-Glycosylation by N-Acetylgalactosaminyltransferase 6 (GALNT6) in Its Nuclear Localization in Breast Cancer Cells.

Deng B, Tarhan YE, Ueda K, Ren L, Katagiri T, Park JH, Nakamura Y.

Neoplasia. 2018 Oct;20(10):1038-1044. doi: 10.1016/j.neo.2018.08.006. Epub 2018 Sep 9.

9.

A potential novel option for cancer immunotherapy - TLR7 stimulation inhibits malignant melanoma bone invasion.

Katagiri T.

Oncotarget. 2018 Aug 7;9(61):31792. doi: 10.18632/oncotarget.25872. eCollection 2018 Aug 7. No abstract available.

10.

Dosimetric comparison between dual-isocentric dynamic conformal arc therapy and mono-isocentric volumetric-modulated arc therapy for two large brain metastases.

Uto M, Mizowaki T, Ogura K, Mukumoto N, Katagiri T, Takehana K, Hiraoka M.

J Radiat Res. 2018 Nov 1;59(6):774-781. doi: 10.1093/jrr/rry064.

11.

α-particle therapy for synovial sarcoma in the mouse using an astatine-211-labeled antibody against frizzled homolog 10.

Li HK, Sugyo A, Tsuji AB, Morokoshi Y, Minegishi K, Nagatsu K, Kanda H, Harada Y, Nagayama S, Katagiri T, Nakamura Y, Higashi T, Hasegawa S.

Cancer Sci. 2018 Jul;109(7):2302-2309. doi: 10.1111/cas.13636. Epub 2018 Jun 27.

12.

A first-in-human study investigating biodistribution, safety and recommended dose of a new radiolabeled MAb targeting FZD10 in metastatic synovial sarcoma patients.

Giraudet AL, Cassier PA, Iwao-Fukukawa C, Garin G, Badel JN, Kryza D, Chabaud S, Gilles-Afchain L, Clapisson G, Desuzinges C, Sarrut D, Halty A, Italiano A, Mori M, Tsunoda T, Katagiri T, Nakamura Y, Alberti L, Cropet C, Baconnier S, Berge-Montamat S, Pérol D, Blay JY.

BMC Cancer. 2018 Jun 8;18(1):646. doi: 10.1186/s12885-018-4544-x.

13.

Heterogeneity of intrahepatic iron deposition in transfusion-dependent iron overload patients with hematological malignancies.

Kobayashi H, Yoshimura N, Uemura S, Katagiri T, Tanaka T, Ushiki T, Fuse K, Shibasaki Y, Narita M, Sone H, Masuko M.

Leuk Res. 2018 May 21;70:41-44. doi: 10.1016/j.leukres.2018.05.005. [Epub ahead of print] No abstract available.

PMID:
29803982
14.

Refinement of the Glasgow Prognostic Score as a pre-transplant risk assessment for allogeneic hematopoietic cell transplantation.

Shibasaki Y, Suwabe T, Katagiri T, Tanaka T, Ushiki T, Fuse K, Sato N, Yano T, Kuroha T, Hashimoto S, Narita M, Furukawa T, Sone H, Masuko M.

Int J Hematol. 2018 May 9. doi: 10.1007/s12185-018-2463-x. [Epub ahead of print]

PMID:
29744806
15.

BMPR2 inhibits activin and BMP signaling via wild-type ALK2.

Olsen OE, Sankar M, Elsaadi S, Hella H, Buene G, Darvekar SR, Misund K, Katagiri T, Knaus P, Holien T.

J Cell Sci. 2018 Jun 11;131(11). pii: jcs213512. doi: 10.1242/jcs.213512.

16.

Sustained clonal hematopoiesis by HLA-lacking hematopoietic stem cells without driver mutations in aplastic anemia.

Imi T, Katagiri T, Hosomichi K, Zaimoku Y, Hoang Nguyen V, Nakagawa N, Tajima A, Yoshizato T, Ogawa S, Nakao S.

Blood Adv. 2018 May 8;2(9):1000-1012. doi: 10.1182/bloodadvances.2017013953.

17.

Infrared Hollow Optical Fiber Probe for Localized Carbon Dioxide Measurement in Respiratory Tracts.

Katagiri T, Shibayama K, Iida T, Matsuura Y.

Sensors (Basel). 2018 Mar 27;18(4). pii: E995. doi: 10.3390/s18040995.

18.

Effects of FKBP12 and type II BMP receptors on signal transduction by ALK2 activating mutations associated with genetic disorders.

Machiya A, Tsukamoto S, Ohte S, Kuratani M, Fujimoto M, Kumagai K, Osawa K, Suda N, Bullock AN, Katagiri T.

Bone. 2018 Jun;111:101-108. doi: 10.1016/j.bone.2018.03.015. Epub 2018 Mar 15.

19.

HIF-1 maintains a functional relationship between pancreatic cancer cells and stromal fibroblasts by upregulating expression and secretion of Sonic hedgehog.

Katagiri T, Kobayashi M, Yoshimura M, Morinibu A, Itasaka S, Hiraoka M, Harada H.

Oncotarget. 2018 Jan 11;9(12):10525-10535. doi: 10.18632/oncotarget.24156. eCollection 2018 Feb 13.

20.

Frequent downregulation of LRRC26 by epigenetic alterations is involved in the malignant progression of triple-negative breast cancer.

Miyagawa Y, Matsushita Y, Suzuki H, Komatsu M, Yoshimaru T, Kimura R, Yanai A, Honda J, Tangoku A, Sasa M, Miyoshi Y, Katagiri T.

Int J Oncol. 2018 Mar 5. doi: 10.3892/ijo.2018.4301. [Epub ahead of print]

PMID:
29512727
21.

Hematopoiesis by iPSC-derived hematopoietic stem cells of aplastic anemia that escape cytotoxic T-cell attack.

Espinoza JL, Elbadry MI, Chonabayashi K, Yoshida Y, Katagiri T, Harada K, Nakagawa N, Zaimoku Y, Imi T, Takamatsu H, Ozawa T, Maruyama H, Hassanein HA, Khalifa A Noreldin A, Takenaka K, Akashi K, Hamana H, Kishi H, Akatsuka Y, Nakao S.

Blood Adv. 2018 Feb 27;2(4):390-400. doi: 10.1182/bloodadvances.2017013342. Erratum in: Blood Adv. 2018 Sep 11;2(17):2253.

22.

A DDX31/Mutant-p53/EGFR Axis Promotes Multistep Progression of Muscle-Invasive Bladder Cancer.

Daizumoto K, Yoshimaru T, Matsushita Y, Fukawa T, Uehara H, Ono M, Komatsu M, Kanayama HO, Katagiri T.

Cancer Res. 2018 May 1;78(9):2233-2247. doi: 10.1158/0008-5472.CAN-17-2528. Epub 2018 Feb 13.

PMID:
29440146
23.

Molecular targeting of cell-permeable peptide inhibits pancreatic ductal adenocarcinoma cell proliferation.

Sato S, Nakamura T, Katagiri T, Tsuchikawa T, Kushibiki T, Hontani K, Takahashi M, Inoko K, Takano H, Abe H, Takeuchi S, Ono M, Kuwabara S, Umemoto K, Suzuki T, Sato O, Nakamura Y, Hirano S.

Oncotarget. 2017 Oct 19;8(69):113662-113672. doi: 10.18632/oncotarget.21939. eCollection 2017 Dec 26.

24.

Present status and future perspective of peptide-based vaccine therapy for urological cancer.

Obara W, Kanehira M, Katagiri T, Kato R, Kato Y, Takata R.

Cancer Sci. 2018 Mar;109(3):550-559. doi: 10.1111/cas.13506. Epub 2018 Feb 15. Review.

25.

The AP-1 transcription factor JunB is required for Th17 cell differentiation.

Yamazaki S, Tanaka Y, Araki H, Kohda A, Sanematsu F, Arasaki T, Duan X, Miura F, Katagiri T, Shindo R, Nakano H, Ito T, Fukui Y, Endo S, Sumimoto H.

Sci Rep. 2017 Dec 12;7(1):17402. doi: 10.1038/s41598-017-17597-3.

26.

Anthelmintic activity of Rosmarinus officinalis against Dactylogyrus minutus (Monogenea) infections in Cyprinus carpio.

Zoral MA, Futami K, Endo M, Maita M, Katagiri T.

Vet Parasitol. 2017 Nov 30;247:1-6. doi: 10.1016/j.vetpar.2017.09.013. Epub 2017 Sep 14.

PMID:
29080753
27.

Scopranones with Two Atypical Scooplike Moieties Produced by Streptomyces sp. BYK-11038.

Uchida R, Lee D, Suwa I, Ohtawa M, Watanabe N, Demachi A, Ohte S, Katagiri T, Nagamitsu T, Tomoda H.

Org Lett. 2017 Nov 3;19(21):5980-5983. doi: 10.1021/acs.orglett.7b03003.

PMID:
29063763
28.

Hyponatremia with Loss of High Signal Intensity in the Posterior Pituitary Lobe on T1-weighted Magnetic Resonance Imaging.

Kitagawa M, Yamanaka Y, Adachi T, Ito J, Fukase K, Ohta I, Katagiri T.

Intern Med. 2017 Dec 1;56(23):3205-3209. doi: 10.2169/internalmedicine.8616-16. Epub 2017 Oct 11.

29.

Diabetic Hemichorea-hemiballism after Prompt Improvement in Hyperglycemia.

Kitagawa M, Yamanaka Y, Adachi T, Ito J, Fukase K, Ohta I, Katagiri T.

Intern Med. 2017 Nov 15;56(22):3073-3076. doi: 10.2169/internalmedicine.8615-16. Epub 2017 Sep 25.

30.

Tumor size and proliferative marker geminin rather than Ki67 expression levels significantly associated with maximum uptake of 18F-deoxyglucose levels on positron emission tomography for breast cancers.

Nishimukai A, Inoue N, Kira A, Takeda M, Morimoto K, Araki K, Kitajima K, Watanabe T, Hirota S, Katagiri T, Nakamori S, Akazawa K, Miyoshi Y.

PLoS One. 2017 Sep 8;12(9):e0184508. doi: 10.1371/journal.pone.0184508. eCollection 2017.

31.

Successful 5-azacytidine treatment of myeloid sarcoma and leukemia cutis associated with myelodysplastic syndrome: A case report and literature review.

Katagiri T, Ushiki T, Masuko M, Tanaka T, Miyakoshi S, Fuse K, Shibasaki Y, Takizawa J, Aoki S, Sone H.

Medicine (Baltimore). 2017 Sep;96(36):e7975. doi: 10.1097/MD.0000000000007975. Review.

32.

The Glasgow Prognostic Score as a pre-transplant risk assessment for allogeneic hematopoietic cell transplantation.

Shibasaki Y, Suwabe T, Katagiri T, Tanaka T, Kobayashi H, Fuse K, Ushiki T, Sato N, Yano T, Kuroha T, Hashimoto S, Narita M, Furukawa T, Sone H, Masuko M.

Clin Transplant. 2017 Nov;31(11). doi: 10.1111/ctr.13103. Epub 2017 Oct 22.

PMID:
28871665
33.

Immune-Mediated Hematopoietic Failure after Allogeneic Hematopoietic Stem Cell Transplantation: A Common Cause of Late Graft Failure in Patients with Complete Donor Chimerism.

Maruyama K, Aotsuka N, Kumano Y, Sato N, Kawashima N, Onda Y, Maruyama H, Katagiri T, Zaimoku Y, Nakagawa N, Hosomichi K, Ogawa S, Nakao S.

Biol Blood Marrow Transplant. 2018 Jan;24(1):43-49. doi: 10.1016/j.bbmt.2017.08.018. Epub 2017 Aug 30.

34.

Heterotopic bone induction via BMP signaling: Potential therapeutic targets for fibrodysplasia ossificans progressiva.

Katagiri T, Tsukamoto S, Kuratani M.

Bone. 2018 Apr;109:241-250. doi: 10.1016/j.bone.2017.07.024. Epub 2017 Jul 25. Review.

35.

Relationship between Contrast Enhancement of the Perivascular Space in the Basal Ganglia and Endolymphatic Volume Ratio.

Ohashi T, Naganawa S, Katagiri T, Kuno K.

Magn Reson Med Sci. 2018 Jan 10;17(1):67-72. doi: 10.2463/mrms.mp.2017-0001. Epub 2017 Jun 8.

36.

A-kinase anchoring protein BIG3 coordinates oestrogen signalling in breast cancer cells.

Yoshimaru T, Ono M, Bando Y, Chen YA, Mizuguchi K, Shima H, Komatsu M, Imoto I, Izumi K, Honda J, Miyoshi Y, Sasa M, Katagiri T.

Nat Commun. 2017 May 30;8:15427. doi: 10.1038/ncomms15427.

37.

The prediction models for postoperative overall survival and disease-free survival in patients with breast cancer.

Shigemizu D, Iwase T, Yoshimoto M, Suzuki Y, Miya F, Boroevich KA, Katagiri T, Zembutsu H, Tsunoda T.

Cancer Med. 2017 Jul;6(7):1627-1638. doi: 10.1002/cam4.1092. Epub 2017 May 24.

38.

Global assessments of disease activity are age-dependent determinant factors of clinical remission in rheumatoid arthritis.

Ito H, Ogura T, Hirata A, Takenaka S, Mizushina K, Fujisawa Y, Katagiri T, Hayashi N, Kameda H.

Semin Arthritis Rheum. 2017 Dec;47(3):310-314. doi: 10.1016/j.semarthrit.2017.04.008. Epub 2017 Apr 28.

39.

Comprehensive evaluation of immunomodulation by moderate hypoxia in S. agalactiae vaccinated Nile tilapia.

Gallage S, Katagiri T, Endo M, Maita M.

Fish Shellfish Immunol. 2017 Jul;66:445-454. doi: 10.1016/j.fsi.2017.05.041. Epub 2017 May 16.

PMID:
28526572
40.

Serum p53 antibody as a potential tumor marker in extrahepatic cholangiocarcinoma.

Okada R, Shimada H, Otsuka Y, Tsuchiya M, Ishii J, Katagiri T, Maeda T, Kubota Y, Nemoto T, Kaneko H.

Surg Today. 2017 Dec;47(12):1492-1499. doi: 10.1007/s00595-017-1540-8. Epub 2017 May 15.

PMID:
28508195
41.

Stapled BIG3 helical peptide ERAP potentiates anti-tumour activity for breast cancer therapeutics.

Yoshimaru T, Aihara K, Komatsu M, Matsushita Y, Okazaki Y, Toyokuni S, Honda J, Sasa M, Miyoshi Y, Otaka A, Katagiri T.

Sci Rep. 2017 May 12;7(1):1821. doi: 10.1038/s41598-017-01951-6.

42.

Immunohistochemical Ki67 after short-term hormone therapy identifies low-risk breast cancers as reliably as genomic markers.

Iwamoto T, Katagiri T, Niikura N, Miyoshi Y, Kochi M, Nogami T, Shien T, Motoki T, Taira N, Omori M, Tokuda Y, Fujiwara T, Doihara H, Gyorffy B, Matsuoka J.

Oncotarget. 2017 Apr 18;8(16):26122-26128. doi: 10.18632/oncotarget.15385.

43.

Development of a dye molecule-biocatalyst hybrid system with visible-light induced carbon-carbon bond formation from CO2 as a feedstock.

Amao Y, Ikeyama S, Katagiri T, Fujita K.

Faraday Discuss. 2017 Jun 2;198:73-81. doi: 10.1039/c6fd00212a.

PMID:
28276560
44.

Identification of an HLA class I allele closely involved in the autoantigen presentation in acquired aplastic anemia.

Zaimoku Y, Takamatsu H, Hosomichi K, Ozawa T, Nakagawa N, Imi T, Maruyama H, Katagiri T, Kishi H, Tajima A, Muraguchi A, Kashiwase K, Nakao S.

Blood. 2017 May 25;129(21):2908-2916. doi: 10.1182/blood-2016-11-752378. Epub 2017 Feb 23. Erratum in: Blood. 2017 Aug 24;130(8):1072.

45.

Successful umbilical cord blood hematopoietic stem cell transplantation in a patient with adult T-cell leukemia/lymphoma initially achieving complete remission with anti-CC chemokine receptor 4 antibody combined chemotherapy.

Suwabe T, Shibasaki Y, Kaihatsu A, Katagiri T, Miyakoshi S, Fuse K, Kobayashi H, Ushiki T, Moriyama M, Takizawa J, Narita M, Sone H, Masuko M.

Rinsho Ketsueki. 2017;58(1):32-36. doi: 10.11406/rinketsu.58.32. Japanese.

PMID:
28190863
46.

Sex- and age-dependent gene expression in human liver: An implication for drug-metabolizing enzymes.

Uno Y, Takata R, Kito G, Yamazaki H, Nakagawa K, Nakamura Y, Kamataki T, Katagiri T.

Drug Metab Pharmacokinet. 2017 Feb;32(1):100-107. doi: 10.1016/j.dmpk.2016.10.409. Epub 2016 Oct 27.

PMID:
28153492
47.

Protein kinase A inhibition facilitates the antitumor activity of xanthohumol, a valosin-containing protein inhibitor.

Shikata Y, Yoshimaru T, Komatsu M, Katoh H, Sato R, Kanagaki S, Okazaki Y, Toyokuni S, Tashiro E, Ishikawa S, Katagiri T, Imoto M.

Cancer Sci. 2017 Apr;108(4):785-794. doi: 10.1111/cas.13175. Epub 2017 Apr 20.

48.

Outbreaks of ulcerative disease associated with ranavirus infection in barcoo grunter, Scortum barcoo (McCulloch & Waite).

Kayansamruaj P, Rangsichol A, Dong HT, Rodkhum C, Maita M, Katagiri T, Pirarat N.

J Fish Dis. 2017 Oct;40(10):1341-1350. doi: 10.1111/jfd.12606. Epub 2017 Jan 23.

PMID:
28111768
49.

Feasibility and Technique for Transvaginal Natural Orifice Transluminal Endoscopic Surgery Liver Resection: A Porcine Model.

Katagiri T, Otsuka Y, Horgan S, Sandler BJ, Jacobsen GR, Coker AM, Tsuchiya M, Maeda T, Kaneko H.

Surg Laparosc Endosc Percutan Tech. 2017 Feb;27(1):e6-e11. doi: 10.1097/SLE.0000000000000367.

50.

Supplemental Content

Loading ...
Support Center